Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 27, 2026
Comparative Risk of Adverse Cardiovascular Outcomes With Zanubrutinib Versus Ibrutinib in B-Cell Malignancies: A Large Real-World Propensity-Matched Analysis.
Journal: The American journal of cardiology
Published: February 26, 2026
Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 19, 2025
Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM.
Journal: Blood advances
Published: December 08, 2025
Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM.
Journal: Blood advances
Published: December 08, 2025
Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 07, 2025
Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 23, 2024
Plain language summary of the TRANSFORM study primary analysis results: liso-cell as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen.
Journal: Future oncology (London, England)
Published: March 28, 2024
Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy.
Journal: Blood advances
Published: March 25, 2024
Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: August 31, 2023
Last Updated: 09/26/2026